Tests bumetanide against placebo in children with autism
Tests bumetanide, compared with placebo, in children with autism spectrum disorder.
Plain-language title generated from the registry record
Registry title: Role of Bumetanide in Treatment of Autism
Key facts
- Where
- Tanta, EgyptSee the site
- Phase
- Phase 3
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 3 and 12 years old?
Source: NCT04766177, who can take part
Where in Egypt
- Sherief Abd-ElsalamTanta, EgyptTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Sherief Abd-Elsalam
- Trial code
- NCT04766177
- Record updated
- 23 February 2021
- Original description
Role of bumetanide in AutismRead full original descriptionShow less
Role of Bumetanide in Treatment of Autism Spectrum Disorder in Children
Role of bumetanide in Autism
Inclusion: All patients with ASD diagnosed by CARS rating Scale⩾30; Age of patients range between (3-12) years.
Exclusion: Patients with ASD associated with neurological antecedents (including epilepsies and febrile seizures), hepatic, renal dysfunction or electrocardiogram abnormalities and syndromatic children(Rett).